|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 14/605 | (2006.01) |
| A61K 38/26 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 3321279 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16848039.0 |
| Date of filing the European patent application | 2016-09-13 | |
| (97) | Date of publication of the European application | 2018-05-16 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-12 |
| (46) | Date of publication of the claims translation | 2020-04-10 |
| (86) | Number | PCT/CN2016/098844 |
| Date | 2016-09-13 |
| (87) | Number | WO 2017/050157 |
| Date | 2017-03-30 |
| (30) | Number | Date | Country code |
| 201510619012 | 2015-09-25 | CN |
| (72) |
YUAN, Jiandong, CN
HUANG, Yangqing, CN
SONG, Yunsong, CN
YUAN, Fang, CN
|
| (73) |
BrightGene Bio-Medical Technology Co., Ltd.,
Building C25, No. 218 Xinghu Street, BioBay Suzhou Industrial Park Suzhou Jiangsu 215123,
CN
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Eksenatido modifikatorius ir jo panaudojimas |
| EXENATIDE MODIFIER AND USE THEREOF |
| Payment date | Validity (years) | Amount | |
| 2021-08-31 | 6 | 139.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-09-13 |